According to Portage Biotech's latest financial reports the company has $5.34 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $10.54 M | -54.84% |
2022-03-31 | $23.35 M | 743.03% |
2021-03-31 | $2.77 M | -13.98% |
2020-03-31 | $3.22 M | -48.64% |
2019-03-31 | $6.26 M | -17.21% |
2018-03-31 | $7.57 M | -87.18% |
2017-03-31 | $59.07 M | 1159.82% |
2016-03-31 | $4.68 M | 172.88% |
2015-03-31 | $1.71 M | -15.44% |
2014-03-31 | $2.03 M | -38.77% |
2013-03-31 | $3.31 M | 1057.87% |
2012-03-31 | $0.28 M | -87.61% |
2011-03-31 | $2.31 M | -37.38% |
2010-03-31 | $3.69 M | 222.98% |
2009-03-31 | $1.14 M | -75.93% |
2008-03-31 | $4.75 M | -13.38% |
2007-03-31 | $5.48 M | 26.92% |
2006-03-31 | $4.32 M | 458.4% |
2005-03-31 | $0.77 M | 102.85% |
2004-03-31 | $0.38 M | 2722.84% |
2003-03-31 | $0.01 M | -54.79% |
2002-03-31 | $0.02 M | -40.18% |
2001-03-31 | $0.05 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.13 M | -97.53% | Bahamas |
NRC Health
NRC | $1.69 M | -68.19% | ๐บ๐ธ USA |